TCI Wealth Advisors, Inc. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$10,619
+797.6%
706
+606.0%
0.00%
Q4 2022$1,183
+18.3%
1000.0%0.00%
Q3 2022$1,0001000.0%0.00%
Q2 2022$0
-100.0%
100
-60.0%
0.00%
-100.0%
Q4 2021$5,000
-28.6%
250
+25.0%
0.00%0.0%
Q3 2021$7,000
-41.7%
200
-37.3%
0.00%
-50.0%
Q2 2021$12,000
-20.0%
3190.0%0.00%
-66.7%
Q1 2021$15,000
-6.2%
319
+6.3%
0.01%
-14.3%
Q4 2020$16,000
+100.0%
3000.0%0.01%
+133.3%
Q3 2020$8,000
+33.3%
3000.0%0.00%0.0%
Q2 2020$6,000
+50.0%
300
-25.0%
0.00%
+50.0%
Q1 2020$4,000
-33.3%
400
-20.0%
0.00%0.0%
Q4 2019$6,000
+50.0%
500
-28.6%
0.00%0.0%
Q3 2019$4,000
-33.3%
7000.0%0.00%
-33.3%
Q2 2019$6,0000.0%7000.0%0.00%0.0%
Q1 2019$6,000
+200.0%
700
+16.7%
0.00%
+200.0%
Q4 2018$2,0000.0%600
+100.0%
0.00%0.0%
Q3 2018$2,000
+100.0%
300
+200.0%
0.00%
Q2 2018$1,000
-50.0%
100
-50.0%
0.00%
-100.0%
Q4 2017$2,0000.0%2000.0%0.00%0.0%
Q3 2017$2,0002000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders